Rare Ion-Channel Variants More Common in Concussion Cohort
The genetic association and the separate glucagon structure measurements support targeted biological investigation, not validated concussion prediction or evidence of better patient outcomes.
Evidence
Selected rare variants in ion-channel genes were more common among 93 unrelated people with at least one concussion than in selected population-database controls. Ion channels are proteins that regulate the movement of charged particles across cell membranes. The concussion sequencing study, published September 12, 2026, reported a variant-burden odds ratio of 5.44 across 16 ion-channel-related genes. This compared the occurrence of selected variants; it did not show that carriers had 5.44 times the individual concussion risk. The reported 95% confidence interval, 4.13–7.18, describes statistical uncertainty around the estimate.
Researchers used whole-exome sequencing, which examines protein-coding DNA, and filtered variants occurring at frequencies below 2% in migraine, ion-channel and neurotransmission genes. Neurotransmission means signaling between nerve cells. Variants had to be predicted damaging by at least two computer tools and pass visual inspection of sequencing data. Across 24 genes, researchers identified 62 different missense variants—changes that alter a protein building block—in 59 participants, or 63%; 26 participants carried at least two. Selected variants were also tested in 280 migraine cases and 280 age- and sex-matched controls.
A separate glucagon formulation experiment, published September 1, 2026, compared three laboratory preparations of glucagon, a hormone made from a short chain of amino acids. Researchers examined molecular structure using circular dichroism and fluorescence spectroscopy, which use light, and two-dimensional nuclear magnetic resonance, which probes atomic environments.
After one day in Solution A, root-mean-square deviation—a measure of structural variation—rose from 0.0628 to 2.33 angstroms for amino-acid positions 7–14. An angstrom is an atomic-scale unit of distance. For positions 18–21, the measurement changed from 0.0169 to 0.00680 angstroms. Across the investigated environments, destabilization began at the C-terminal region, one end of the molecular chain, while positions 11–14 remained structured. Formulation C had reported purities of 98.34%, 98.36% and 98.37%.
Analysis
Interpretation: These studies identify separate targets for mechanistic investigation: genetic pathways in concussion and vulnerable molecular regions in glucagon preparations. They do not test a shared biological mechanism or confirm each other. Both are single-study findings.
The genetic association can help prioritize experiments testing how variants affect cell function. The glucagon measurements motivate tests of whether preserving particular regions changes stability and aggregation—the clustering of molecules. Neither establishes a usable concussion-risk marker, prognosis tool or patient benefit. Testing selected variants in migraine cases is not replication in another concussion cohort.
Limitations
The genetic cohort was small and consisted of people who had already experienced concussion. Its comparison with population-database controls does not establish causation or individual risk prediction. Predicted damage is not demonstrated disease-causing function: evidence was insufficient to establish that any identified variant causes disease through a single-gene, dominant mechanism, in which one altered gene copy is sufficient.
The glucagon preparations differed in concentration and additives, limiting attribution to any one component. Lactose obscured part of Formulation B’s nuclear magnetic resonance measurements, preventing reliable structural assignment and calculation. Formulation C’s purity results were reported as data not shown. Available study details do not establish the sample size or the period covered by those purity measurements, so the values cannot demonstrate sustained stability or formulation superiority.
What to watch
Confidence in the genetic association would increase if a larger, independent concussion cohort reproduced the variant-burden difference and functional experiments demonstrated relevant biological effects. For glucagon, matched-condition experiments need reported replication counts and timed measurements of structure, purity and aggregation. Reproducing preserved C-terminal structure alongside slower aggregation over a defined interval would strengthen the proposed structure–stability relationship; failure to reproduce that relationship would weaken it.